# Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM

> **NCT02838745** · PHASE1 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 7 (actual)

## Conditions studied

- Mesothelioma

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02838745
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2019-09-05
- **Final completion:** 2019-09-05
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Change in research plan.
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838745, "Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02838745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*